Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression
Authors
Keywords
Alzheimer's disease, Depression, Multi-target-directed ligands, RAGE (Receptor for advanced glycation end products), SERT (Serotonin transporter)
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 236, Issue -, Pages 114347
Publisher
Elsevier BV
Online
2022-04-07
DOI
10.1016/j.ejmech.2022.114347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses
- (2020) Agnieszka Brzezińska et al. Current Alzheimer Research
- Effects of separate or combined exposure of nonylphenol and octylphenol on central 5-HT system and related learning and memory in the rats
- (2019) Huan Liu et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Depression in Alzheimer’s Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?
- (2019) Richard J. Elsworthy et al. JOURNAL OF ALZHEIMERS DISEASE
- Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression
- (2018) Claudia Bartels et al. AMERICAN JOURNAL OF PSYCHIATRY
- Incidence and Course of Depression in Patients with Alzheimer's Disease
- (2017) Seung-Ho Ryu et al. Psychiatry Investigation
- A Novel, Multi-Target Natural Drug Candidate, Matrine, Improves Cognitive Deficits in Alzheimer’s Disease Transgenic Mice by Inhibiting Aβ Aggregation and Blocking the RAGE/Aβ Axis
- (2016) Lili Cui et al. MOLECULAR NEUROBIOLOGY
- Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1
- (2016) Filippo Caraci et al. Frontiers in Pharmacology
- 6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE)
- (2015) Kwanghyun Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fine tuning of 4,6-bisphenyl-2-(3-alkoxyanilino)pyrimidine focusing on the activity-sensitive aminoalkoxy moiety for a therapeutically useful inhibitor of receptor for advanced glycation end products (RAGE)
- (2015) Young Taek Han et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Depression associated with dementia
- (2015) H. Gutzmann et al. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
- Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia
- (2015) Donovan T. Maust et al. JAMA Psychiatry
- Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE)
- (2014) Young Taek Han et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and structure–activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer’s disease
- (2012) Yun Suk Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
- (2012) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- Ligand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors
- (2012) Young Taek Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans
- (2010) Roongpetch Keowkase et al. NEUROPHARMACOLOGY
- Depression in Older Adults
- (2009) Amy Fiske et al. Annual Review of Clinical Psychology
- Site-Specific Blockade of RAGE-Vd Prevents Amyloid- Oligomer Neurotoxicity
- (2008) E. Sturchler et al. JOURNAL OF NEUROSCIENCE
- The Potential for -Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy
- (2008) M.-M. Mocanu et al. JOURNAL OF NEUROSCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now